Roly Foulkes

Company: Revolo Biotherapeutics

Job title: CSO

Seminars:

1104, an Immune-resetting Peptide, for the Treatment of Allergic Disease 12:00 pm

1104 is a short linear peptide that binds to macrophages, and induces a tolerogenic response in allergic individuals and in preclinical models, long after the drug has been cleared from the serum In a human ex vivo study, matched PBMCs from allergics (n=16) and non-allergics (n=12) co-cultured with and without allergen and ‘1104 induced tolerogenic…Read more

day: Day One AM Non-Cell Based Approaches